The Scientist

» cancer, evolution and developmental biology

Most Recent

image: Second Chance for Lost Galapagos Tortoises?

Second Chance for Lost Galapagos Tortoises?

By | September 14, 2017

Researchers are trying to recreate an extinct species of the lumbering reptiles by breeding closely related species that contain traces of the lost lineage’s DNA.

0 Comments

A study of a simple marine animal suggests that the common ancestor of cnidarians and bilaterians may have had three germ layers instead of two.

0 Comments

image: Image of the Day: Fish Avatars for Cancer

Image of the Day: Fish Avatars for Cancer

By | September 11, 2017

Zebrafish larvae transplanted with patients’ tumors respond as their human donors do to chemotherapy.

0 Comments

image: Study: Alcohol Industry Distorts Cancer Risk

Study: Alcohol Industry Distorts Cancer Risk

By | September 10, 2017

Researchers claim that industry groups worldwide misrepresent the carcinogenicity of alcohol products.

0 Comments

image: Mongolian Dinosaurs and the Poaching Problem

Mongolian Dinosaurs and the Poaching Problem

By | September 8, 2017

High-profile cases of poached fossils shine a light on the black market for paleontological specimens—and how scientists and governments are trying to stop it.

1 Comment

image: How Exercise Might Fight Cancer

How Exercise Might Fight Cancer

By | September 8, 2017

Epinephrine’s activation of the signaling pathway Hippo is responsible for the in vitro tumor-fighting effects of serum from women who worked out.

0 Comments

Douglas Lowy and John Schiller, whose work led to the HPV vaccine, and Michael Hall, who discovered the TOR pathway, win this year’s prizes.

0 Comments

image: Fingerprints of Ongoing Human Evolution Found

Fingerprints of Ongoing Human Evolution Found

By | September 5, 2017

Genetic variants in Alzheimer’s- and smoking-related genes appear to be under selection pressure, according to a study comparing the genomes of old and young participants.

1 Comment

image: Gilead to Pay Nearly $12B for CAR T-Cell Company

Gilead to Pay Nearly $12B for CAR T-Cell Company

By | August 28, 2017

The massive sum will buy out Kite Pharma, whose cancer therapy is expected to be among the first of its type approved by the FDA.

0 Comments

image: Global Patterns of Human Epigenetic Variation

Global Patterns of Human Epigenetic Variation

By | August 28, 2017

A study of five far-flung human populations gives clues to adaptations to environmental pressures.

5 Comments

Popular Now

  1. Man Receives First In Vivo Gene-Editing Therapy
  2. Researchers Build a Cancer Immunotherapy Without Immune Cells
  3. Long-term Study Finds That the Pesticide Glyphosate Does Not Cause Cancer
  4. Research Links Gut Health to Neurodegeneration
    The Nutshell Research Links Gut Health to Neurodegeneration

    Rodent studies presented at the Society for Neuroscience meeting this week tie pathologies in the gastrointestinal tract or microbiome composition with Parkinson’s and Alzheimer’s diseases.

RayBiotech